CRNA Providing Monoclonal Antibody Treatments

Monoclonal Antibodies Can Help Those With Covid-19  If you get Covid, it's important to do something right away. You must get monoclonal...

Monoclonal Antibodies Can Help Those With Covid-19 


If you get Covid, it's important to do something right away. You must get monoclonal antibodies to help treat the virus. Fortunately, at this time (October 19th, 2021) monoclonal antibodies are available in the Copper River Valley.

The Copper River Native Association told the Copper River Country Journal on October 19th:

...we currently provide this treatment. The treatment is for confirmed positive or presumed positive patients. We encourage anyone with questions about eligibility to contact our Primary Care team.

 

Antibodies must be taken with the first 10 days of illness.

NEED HELP?

Call CRNA at: 822-5241
Call Cross Road Medical Center at: 822-3203
Call 911 with a medical emergency 


What Are Monoclonal Antibodies? 

According to the website, PhRMA:

In addition to vaccines and antivirals, monoclonal antibodies are important treatment options against the virus that causes COVID-19. Monoclonal antibodies are a type of biologic medicine that play a central role in advancing our ability to treat a range of diseases, including cancer and auto-immune conditions. Monoclonal antibodies are synthetic versions of the body’s antibodies produced in a laboratory and are designed to restore, mimic, inhibit or enhance immune system functions. By building on vast stores of knowledge and information about how these treatments interact with the immune system and can be used to counteract disease, America’s biopharmaceutical researchers have been able to rapidly research and develop monoclonal antibodies that are targeted treatments against the novel coronavirus that causes COVID-19. The National Institutes of Health have put forward treatment guidelines for use of these products.

Decades of biopharmaceutical R&D have enabled the rapid creation and development of targeted monoclonal antibody therapies to treat COVID-19. Monoclonal antibodies are authorized to treat COVID-19 early in the course of illness, within ten days of symptom onset, in outpatient settings, and have been shown to reduce the risk of hospitalization by upwards of 70%. Additionally, monoclonal antibodies can be administered proactively after a potential exposure (post-exposure prophylaxis).

To date, three monoclonal antibodies have been authorized for emergency use by the FDA. These monoclonal antibodies mimic the function of our immune system to help fight COVID-19 by blocking the ability of COVID-19 to attach and enter human cells and/or helping to clear cells which are already infected. The virus must enter the cells to reproduce, as it cannot replicate on its own. By preventing it from doing so or clearing cells in which the virus has already entered, these treatments can help slow the spread of a person’s infection, potentially reducing the length and severity of symptoms.

Related

COVID-19 NEWS 7878850066350565113

Click Here

Native Heritage Month, 2021

Heritage Month: Buster Gene Began Trapping When He Was Only 13 Years Old

Staying Safe At School

Staying Safe At School
What CRNA Will Do To Help If Your Child Has Covid

Too Far North With David Mudrick

Too Far North With David Mudrick

ALASKA 511

ALASKA 511
Click Here To Check Road Conditions Before You Travel

CLICK: TAKE A BREAK

CLICK: TAKE A BREAK
Read The Bearfoot Guide To Roadside Alaska

Stories Folks Are Reading Today

Search For Somebody Below

See Every Single Story

The Journal Is Copyrighted Material

The Journal Is Copyrighted Material
All rights reserved. Contact us at 320-1145.
item